Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...
The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...
Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, ...
InsideHook on MSN
FDA approves first genetic therapy for deafness
Hearing loss is a condition that affect numerous people around the world, but it can take many forms and have many causes. In ...
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
14don MSN
New Gene Therapy Can Restore Hearing in Deaf Kids—And It Comes With an Unexpected Price Tag
A breakthrough FDA-approved treatment is changing how genetic deafness is treated.
Danish dermatology specialist Leo Pharma is paying $50 million for U.S. gene writing biotech Replay and its preclinical gene ...
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseqTM, a ...
We performed a post hoc analysis of a single-center phase II trial (ClinicalTrials.gov identifier: NCT03503643) in which patients with unilateral grade group (GG) 2-4 PCa (n = 108) underwent hemigland ...
New technology enables the insertion of a large segment of DNA into a genome, potentially expanding gene therapy treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results